Unsettling the treatment imperative? Chemotherapy decision-making in the wake of genomic techniques

Ross and colleagues interview breast cancer patients and practitioners about their experiences with Oncotype DX and find that it provides an opportunity to reduce overtreatment, but given sociocultural and organizational contexts that reinforce the treatment imperative, it may not.